Please assess the completion status of the following clinical trial:

Trial Title: Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* History of exercise induced asthma~* Maximum 4 asthmatic episodes per week requiring use of reliever medication~Exclusion Criteria:~* No previous treatment with inhaled oral corticosteroids during the last month before randomisation~* Suspected poor capability to follow instructions, ie to exercise 3-4 times a week

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): budesonide 400yg + terbutaline 0.4 mg as-needed
- B (Type: ACTIVE_COMPARATOR): placebo + terbutaline 0.4 mg as-needed
- C (Type: ACTIVE_COMPARATOR): placebo + budesonide/formoterol 160/4.5 yg as-needed

Based on this trial design, predict the completion outcome and termination type (if applicable).